Skip Navigation


QJM Advance Access originally published online on February 27, 2006
QJM 2006 99(4):237-243; doi:10.1093/qjmed/hcl028
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/4/237    most recent
hcl028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Timmer, J.R.
Right arrow Articles by Zijlstra, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timmer, J.R.
Right arrow Articles by Zijlstra, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes

J.R. Timmer1, J.P. Ottervanger1,, H.J.G. Bilo2, J.H.E. Dambrink1, K. Miedema3, J.C.A. Hoorntje1 and F. Zijlstra4

From the Departments of 1Cardiology, 2Internal Medicine and 3Laboratory Medicine, Isala Klinieken, Zwolle, and 4Department of Cardiology, Thoraxcenter, University Medical Centre, Groningen, The Netherlands

Address correspondence to Dr J.P. Ottervanger, Department of Cardiology, Isala Klinieken, Groot Wezenland 20, 8011 JW Zwolle, The Netherlands. email: v.r.c.derks{at}isala.nl

Received 10 August 2005 and in revised form 16 January 2006

Background: Admission hyperglycaemia is associated with poorer prognosis in patients with an acute coronary syndrome (ACS). Whether hyperglycaemia is more important than prior long-term glucose metabolism, is unknown.

Aim: To investigate the prognostic value of admission glucose and HbA1c levels in patients with ACS.

Methods: We measured glucose and HbA1c at admission in 521 consecutive patients with suspected ACS. Glucose was categorized as <7.8 (n = 305), 7.8–11.0 (n = 138) or >=11.1 mmol/l (n = 78); HbA1c as <6.2% (n = 420) or >=6.2% (n = 101). Mean follow-up was 1.6 ± 0.5 years.

Results: The diagnosis of ACS was confirmed in 332 patients (64%), leaving 189 (36%) with atypical chest pain. In ACS patients, mortality by glucose category (<7.8, 7.8–11.0 or >=11.1 mmol) was 9%, 8% and 25%, respectively (p = 0.001); mortality by HbA1c category (<6.2% vs. >=6.2%) was 10% vs. 17%, respectively (p = 0.14). On multivariate analysis, glucose category was significantly associated with mortality (HR 3.0, 95%CI 1.1–8.3), but HbA1c category was not (HR 1.5, 95%CI 0.6–4.2).

Discussion: Elevated admission glucose appears more important than prior long-term abnormal glucose metabolism in predicting mortality in patients with suspected ACS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JRSMHome page
K. Asadollahi, N. Beeching, and G. Gill
Hyperglycaemia and mortality
J R Soc Med, November 1, 2007; 100(11): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. P. Goran
The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction
Eur. Heart J., August 2, 2007; 28(16): 2042 - 2042.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.